Journal for ImmunoTherapy of Cancer (Nov 2023)
1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models
- Elizabeth Gray,
- Priyanka Gupta,
- Weiping Zeng,
- Shyra Gardai,
- Kaleb Smith,
- Katie Snead,
- Adam Hill,
- Kellie Spahr,
- Alyson J Smith,
- Elizabeth Cummins,
- David Gruber,
- Michelle L Ulrich,
- Mallory Long,
- Katelyn Hinricher,
- Aditi Langalia,
- Patrick Burke,
- Peter Senter
Affiliations
- Elizabeth Gray
- 1Seagen Inc., Bothell, WA, USA
- Priyanka Gupta
- 3Seagen Inc., Foster City, CA, USA
- Weiping Zeng
- 1Seagen Inc., Bothell, WA, USA
- Shyra Gardai
- 1Seagen Inc., Bothell, WA, USA
- Kaleb Smith
- 2Seagen Inc., Seattle, WA, USA
- Katie Snead
- 1Seagen Inc., Bothell, WA, USA
- Adam Hill
- 1Seagen Inc., Bothell, WA, USA
- Kellie Spahr
- 1Seagen Inc., Bothell, WA, USA
- Alyson J Smith
- 1Seagen Inc., Bothell, WA, USA
- Elizabeth Cummins
- 1Seagen Inc., Bothell, WA, USA
- David Gruber
- 1Seagen Inc., Bothell, WA, USA
- Michelle L Ulrich
- 1Seagen Inc., Bothell, WA, USA
- Mallory Long
- 1Seagen Inc., Bothell, WA, USA
- Katelyn Hinricher
- 1Seagen Inc., Bothell, WA, USA
- Aditi Langalia
- 1Seagen Inc., Bothell, WA, USA
- Patrick Burke
- 1Seagen Inc., Bothell, WA, USA
- Peter Senter
- 1Seagen Inc., Bothell, WA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.1114
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
